CG Products Bucket
-
Scale-Up Strategies For Cell And Gene Therapy
10/3/2022
You need to build the right infrastructure and capabilities into the clinical process to support your product’s commercialization.
-
Commercial-Scale Strategies For Cell And Gene Therapy Drug Manufacturers
10/3/2022
Architecting a connected cell and gene therapy organization is critical, whether your goal is to stand alone or with another business. Building this structure starts with defining roles and acquiring talent, then establishing an effective commercial model.
-
Digital Technology For R&D Development In Cell And Gene Therapy
10/3/2022
Cell and gene therapies rely on speed for success. Yet the downstream signaling associated with living therapies present additional complexities to explore. You need the right technology and novel clinical tools to reduce time from bench to bedside.
-
Pricing Strategies For Cell And Gene Therapy
10/3/2022
Today, fewer than 25% of eligible patients benefit from cell and gene therapies. Expanding the impact of these therapies must start early in their development as you plan your network strategy and design flexible contracts with payers and providers.
-
Facility Construction Services For Cell And Gene Therapy Manufacturing
9/26/2022
The Cardinal Group, an IPS Company, approaches the inception of every construction project with the “end in mind”. We will deliver a fully functional project that supports the science, medicine or research for its intended design – as our schedule predicted – to enhance successful facility operations. Cardinal delivers on this promise with our intellectual capital as a true knowledge-based firm with tremendous experience in Front-end Planning, Design Management, Trade & Equipment Procurement, Construction, Start-up, Commissioning and Turnover.
-
in vivo-jetRNA®+
9/14/2022
Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry. -
Elutriation: How It Works
8/18/2022
Our counterflow centrifugation system operates on the principle of elutriation. Elutriation is a process for separating cells based on their size, shape and density. Discover the four stages in the lymphocyte elutriation process.
-
Antibody Therapeutics Purification
8/11/2022
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
-
Facility Location Services For Regenerative Drug Manufacturers
7/27/2022
Where organizations choose to locate is a decision of significant and strategic importance, as decisions on new locations, expansions and consolidations can significantly impact operating and financial performance. More and more, organizations seek to leverage the positive returns that a well-developed location strategy can provide.
-
Real Estate Management Services For Cell And Gene Therapy Drug Manufacturers
7/27/2022
Our knowledgeable real estate team will help you acquire and lease best-in-class gene therapy facilities that advance development of life-saving medicines. Our end-to-end tech-enabled solution helps you gain visibility to portfolio risks and opportunities, create operational efficiencies, and leverage data and benchmarks for improved operational excellence.